Tuberous sclerosis-related gene expression in normal and dysplastic brain

Epilepsy Research

Volumn 32, Issue 1-2, 1998, Pages 12-23

  Vinters, Harry V ^a,b   Kerfoot, Christopher ^a   Catania, Michael ^a   Emelin, Jessica K ^a   Roper, Steven N ^c   Declue, Jeffrey E ^d  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Brain development; Cortical dysplasia; Epilepsy pediatric; Neuronal migration disorder; Tuberin

Indexed keywords

GENE PRODUCT;

BRAIN DEVELOPMENT; BRAIN MALFORMATION; CONFERENCE PAPER; DYSPLASIA; EPILEPSY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; MOLECULAR BIOLOGY; NEUROPATHOLOGY; PRIORITY JOURNAL; TUBEROUS SCLEROSIS;

BRAIN; CEREBRAL CORTEX; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 9; EPILEPSY; HUMANS; INFANT; PROTEINS; REPRESSOR PROTEINS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032167535     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00036-9     Document Type: Conference Paper

References (51)

1. Barinaga M. Guiding neurons to the cortex. Science. 274:1996;1100-1101.
2. Becker L.E. Synaptic dysgenesis. Can. J. Neurol. Sci. 18:1991;170-180.
3. Bronen R.A., Vives K.P., Kim J.H., Fulbright R.K., Spencer S.S., Spencer D.D. Focal cortical dysplasia of Taylor, balloon cell subtype: MR differentiation from low-grade tumors. AJNR Am. J. Neuroradiol. 18:1997;1141-1151.
4. Carbonara C., Longa L., Grosso E., Borrone C., Garrè M.G., Brisigotti M., Migone N. 9p34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum. Mol. Genet. 3:1994;1829-1832.
5. Clark G.D., Mizuguchi M., Antalffy B., Barnes J., Armstrong D. Predominant localization of the LIS family of gene products to Cajal-Retzius cells and ventricular neuroepithelium in the developing human cortex. J. Neuropathol. Exp. Neurol. 56:1997;1044-1052.
6. Crino P.B., Trojanowski J.Q., Dichter M.A., Eberwine J. Embryonic neuronal markers in tuberous sclerosis: Single-cell molecular pathology. Proc. Natl. Acad. Sci. USA. 93:1996;14152-14157.
7. De Rosa M.J., Secor D.L., Barsom M., Fisher R.S., Vinters H.V. Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study. Acta Neuropathol. 84:1992;250-260.
8. Duong T., De Rosa M.J., Poukens V., Vinters H.V., Fisher R.S. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol. 87:1994;493-503.
9. Farrell M.A., De Rosa M.J., Curran J.G., Secor D.L., Cornford M.E., Comair Y.G., Peacock W.J., Shields W.D., Vinters H.V. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol. 83:1992;246-259.
10. Geist R.T., Gutmann D.H. The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Diff. 6:1995;1477-1483.
11. Geist R.T., Reddy A.J., Zhang J., Gutmann D.H. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues. Neurobiol. Dis. 3:1996;111-120.
12. Green A.J., Johnson P.H., Yates J.R.W. The tuberous sclerosis gene on chromosome 9p34 acts as a growth suppressor. Hum. Mol. Genet. 3:1994;1833-1834.
13. Green A.J., Smith M., Yates J.R.W. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat. Genet. 6:1994;193-196.
14. Guerrini, R., Canapicchi, R., Zifkin, B.G., Andermann, F., Roger, J., Pfanner, P. (Eds.), 1996. Dysplasias of Cerebral Cortex and Epilepsy. Lippincott-Raven, Philadelphia-New York.
15. Henske E.P., Scheithauer B.W., Short M.P., Wollmann R., Nahmias J., Hornigold N., van Slegtenhorst M., Welsh C.T., Kwiatkowski D.J. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am. J. Hum. Genet. 59:1996;400-406.
16. Hino O., Kobayashi E., Hirayama Y., Kobayashi T., Kubo Y., Tsuchiya H., Kikuchi Y., Mitani H. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2). Mol. Carcinogenesis. 14:1995;23-27.
17. Jay V., Becker L.E. Surgical pathology of epilepsy: A review. Pediatric Pathol. 14:1994;731-750.
18. Kerfoot C., Wienecke R., Menchine M., Emelin J., Maize J.C. Jr., Welsh C.T., Norman M.G., DeClue J.E., Vinters H.V. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol. 6:1996;367-377.
19. Kuzniecky R.I., Barkovich A.J. Pathogenesis and pathology of focal malformations of cortical development and epilepsy. J. Clin. Neurophysiol. 13:1996;468-480.
20. Lo Nigro C., Chong S.S., Smith A.C.M., Dobyns W.B., Carrozzo R., Ledbetter D.H. Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum. Mol. Genet. 6:1997;157-164.
21. Lopes M.B.S., Altermatt H.J., Scheithauer B.W., Shepherd C.W., VandenBerg S.R. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol. 91:1996;368-375.
22. Menchine M., Emelin J.K., Mischel P.S., Haag T.A., Norman M.G., Pepkowitz S.H., Welsh C.T., Townsend J.J., Vinters H.V. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. Mod. Pathol. 9:1996;1071-1080.
23. Mischel P.S., Nguyen L.P., Vinters H.V. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J. Neuropathol. Exp. Neurol. 54:1995;137-153.
24. Mizuguchi M., Takashima S., Kakita A., Yamada M., Ikeda K. Lissencephaly gene product. Localization in the central nervous system and loss of immunoreactivity in Miller-Dieker syndrome. Am. J. Pathol. 147:1995;1142-1151.
25. Mizuguchi M., Kato M., Yamanouchi H., Ikeda K., Takashima S. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann. Neurol. 40:1996;941-944.
26. Mizuguchi M., Kato M., Yamanouchi H., Ikeda K., Takashima S. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol. 94:1997;525-531.
27. Palmini A., Andermann F., Olivier A., Tampieri D., Robitaille Y., Andermann E., Wright G. Focal neuronal migration disorders and intractable partial epilepsy: A study of 30 patients. Ann. Neurol. 30:1991;741-749.
28. Park S.-H., Pepkowitz S.H., Kerfoot C., De Rosa M.J., Poukens V., Wienecke R., DeClue J.E., Vinters H.V. Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathol. 94:1997;180-186.
29. Platten M., Meyer-Puttlitz B., Blümcke I., Waha A., Wolf H.K., Nöthen M.M., Louis D.N., Sampson J.R., von Deimling A. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas. J. Neuropathol. Exp. Neurol. 56:1997;806-810.
30. Reiner O., Carrozzo R., Shen Y., Wehnert M., Faustinella F., Dobyns W.B., Caskey C.T., Ledbetter D.H. Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature. 364:1993;717-721.
31. Roper S.N., Gilmore R.L., Houser C.R. Experimentally induced disorders of neuronal migration produce an increased propensity for electrographic seizures in rats. Epilepsy Res. 21:1995;205-219.
32. Rorke L.B. The role of disordered genetic control of neurogenesis in the pathogenesis of migration disorders. J. Neuropathol. Exp. Neurol. 53:1994;105-117.
33. Ross M.E., Allen K.M., Srivastava A.K., Featherstone T., Gleeson J.G., Hirsch B., Harding B.N., Andermann E., Abdullah R., Berg M.et al. Linkage and mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brain. Hum. Mol. Genet. 6:1997;555-562.
34. Sampson J.R., Harris P.C. The molecular genetics of tuberous sclerosis. Hum. Mol. Genet. 3:1994;1477-1480.
35. Sarnat H.B. Cerebral dysplasias as expressions of altered maturational processes. Can. J. Neurol. Sci. 18:1991;196-204.
36. Taylor D.C., Falconer M.A., Bruton C.J., Corsellis J.A.N. Focal dysplasia of the cerebral cortex in epilepsy. J. Neurol. Neurosurg. Psychiatry. 34:1971;369-387.
37. The European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 75:1993;1305-1315.
38. Trottier S., Evrard B., Vignal J.-P., Scarabin J.-M., Chauvel P. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res. 25:1996;79-106.
39. van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., Lindhout D., van den Ouweland A., Halley D., Young J., Burley M., Jeremiah S., Woodward K.et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 277:1997;805-808.
40. Vinters H.V., Fisher R.S., Cornford M.E., Mah V., Secor D.L., DeRosa M.J., Comair Y.G., Peacock W.J., Shields W.D. Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Child Nerv. Syst. 8:1992;8-17.
41. Vinters H.V., De Rosa M.J., Farrell M.A. Neuropathologic study of resected cerebral tissue from patients with infantile spasms. Epilepsia. 34:1993;772-779.
42. Vinters H.V., Kerfoot C., Emelin J.K. Tuberin loss from cerebral tissues. Ann. Neurol. 42:1997;270-271.
43. Wienecke R., König A., DeClue J.E. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem. 270:1995;16409-16414.
44. Wienecke R., Maize J.C. Jr., Shoarinejad F., Vass W.C., Reed J., Bonifacino J.S., Resau J.H., de Gunzburg J., Yeung R.S., DeClue J.E. Co-localization of the TSC2 product tuberin with its target Rap1 in the golgi apparatus. Oncogene. 13:1996;913-923.
45. Wienecke R., Guha A., Maize J.C. Jr., Heideman R.L., DeClue J.E., Gutmann D.H. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas. Ann. Neurol. 42:1997;230-235.
46. Wienecke R., Maize J.C. Jr., Reed J.A., de Gunzburg J., Yeung R.S., DeClue J.E. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am. J. Pathol. 150:1997;43-50.
47. Wilson P.J., Ramesh V., Kristiansen A., Bove C., Jozwiak S., Kwiatkowski D.J., Short M.P., Haines J.L. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum. Mol. Genet. 5:1996;249-256.
48. Wolf H.K., Zentner J., Hufnagel A., Campos M.G., Schramm J., Elger C.E., Wiestler O.D. Surgical pathology of chronic epileptic seizure disorders: experience with 63 specimens from extratemporal corticectomies, lobectomies and functional hemispherectomies. Acta Neuropathol. 86:1993;466-472.
49. Wolf H.K., Normann S., Green A.J., von Bakel I., Blumcke I., Pietsch T., Wiestler O.D., von Deimling A. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions. Acta Neuropathol. 93:1997;93-96.
50. Xu L., Sterner C., Maheshwar M.M., Wilson P.J., Nellist M., Short P.M., Haines J.L., Sampson J.R., Ramesh V. Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues. Genomics. 27:1995;475-480.
51. Yeung R.S., Xiao G.-H., Everitt J.I., Jin F., Walker C.L. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol. Carcinogenesis. 14:1995;28-36.